Led by $13bn acquisition of Change Healthcare, North America’s medical devices industry saw a rise of 13.91% in deal activity during Q1 2021, when compared to the last four-quarter average, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 301 deals worth $31.45bn were announced for the region during Q1 2021, against the last four-quarter average of 264.25 deals.
Of all the deal types, venture financing saw most activity in Q1 2021 with 182 deals, representing a 60.5% share for the region.
In second place was M&A with 94 deals, followed by private equity deals with 25 transactions, respectively capturing a 31.2% and 8.3% share of the overall deal activity for the quarter.
In terms of value of deals, M&A was the leading category in North America’s medical devices industry with $26.81bn, while venture financing and private equity deals totalled $3.1bn and $1.54bn, respectively.
North America medical devices industry deals in Q1 2021: Top deals
The top five medical devices deals accounted for a 65.6% share of the overall value during Q1 2021.
The combined value of the top five deals stood at $20.63bn, against the overall value of $31.45bn recorded for the quarter.
The top five medical devices industry deals of Q1 2021 tracked by GlobalData were:
1) OptumInsight’s $13bn acquisition of Change Healthcare
2) The $4.6bn acquisition of Cantel Medical by Steris
3) Boston Scientific’s $1.23bn acquisition of Preventice
4) The $1bn private equity deal with Cardinal Health by Hellman & Friedman
5) Corza Health’s acquisition of Surgical Specialties for $800m.